Statistics

Total Visits

Views
The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial 126
The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial 88

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial 3 9 5 6 15 9 0

File Downloads

Views

Top Country Views

Views
United States 102
France 26
China 20
Germany 12
Australia 11
Netherlands 9
Vietnam 8
India 2
Sweden 2
Greece 1

Top City Views

Views
Ashburn 36
Hanoi 8
Kaleen 8
Rotterdam 8
Fairfield 7
Beijing 5
Cambridge 5
Boardman 4
Dearborn 3
Buffalo 2